# Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival

> **NCT00742001** · PHASE1 · TERMINATED · sponsor: **Terumo BCTbio** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Mirasol System for Whole Blood.

## Key facts

- **NCT ID:** NCT00742001
- **Lead sponsor:** Terumo BCTbio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09-10
- **Primary completion:** 2008-11-20
- **Final completion:** 2008-12-16
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** An endpoint difference between 3 energies was not observed at interim analysis
- **Last updated:** 2019-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742001, "Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00742001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*